Xi Yan
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
-
- Antifungal resistance and susceptibility
Papers in
- Oncology 15
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 6
-
- Cancer, Hypoxia, and Metabolism 8
- Breast Cancer Treatment Studies 6
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Feng Luo (8 shared papers)Ming Jiang (4 shared papers)Liqun Zou (2 shared papers)Yu Jiang (2 shared papers)Mei Li (1 shared paper)Yanyang Liu (3 shared papers)Zhixi Li (2 shared papers)Tao Ning (5 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Human Gene Therapy (2 papers)Annals of Oncology (2 papers)Cancer (1 paper)Nature Medicine (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xi Yan
27 papers receiving 346 citations
Xi Yan's Hit Papers
Peers
Comparison fields: 5 of 66
- Cancer Research 96
- Infectious Diseases 80
- Small Animals 31
- Oncology 107
- Epidemiology 85
Countries citing papers authored by Xi Yan
This map shows the geographic impact of Xi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Yan more than expected).
Fields of papers citing papers by Xi Yan
This network shows the impact of papers produced by Xi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Yan. The network helps show where Xi Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 81 | |
| 2 | 2015 | 31 | |
| 3 | 2019 | 27 | |
| 4 | 2022 | 21 | |
| 5 | 2024 | 21 | |
| 6 | 2012 | 18 | |
| 7 | 2009 | 17 | |
| 8 | Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial Hit paper breakdown → | 2025 | 16 |
| 9 | 2020 | 14 | |
| 10 | 2011 | 14 | |
| 11 | 2012 | 13 | |
| 12 | 2012 | 13 | |
| 13 | 2024 | 8 | |
| 14 | 2023 | 8 | |
| 15 | 2012 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2014 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2008 | 5 | |
| 20 | 2024 | 5 |
About Xi Yan
Xi Yan is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 35 papers that have together received 349 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Advanced Breast Cancer Therapies (7 papers), Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (6 papers), Immune cells in cancer (4 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (96 citations), Infectious Diseases (80 citations), Small Animals (31 citations), Oncology (107 citations) and Epidemiology (85 citations). Xi Yan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Feng Luo, Ming Jiang, Liqun Zou, Yu Jiang, Mei Li, Yanyang Liu, Zhixi Li, Tao Ning, Xia Wang and Qian Peng. Their work appears in journals such as Journal of Clinical Oncology, Human Gene Therapy, Annals of Oncology, Cancer and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.